US District Court upholds US FDA's grant of 5 yrs market exclusivity to Vyvanse pharmabiz.com On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of Vyanse, the US FDA determined that Vyvanse qualified as an NCE ... |
District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) PR-CANADA.net (press release) On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of VYVANSE, the FDA determined that VYVANSE qualified as an NCE ... |
District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) FOXBusiness On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of VYVANSE, the FDA determined that VYVANSE qualified as an NCE ... |
District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) Trading Markets (press release) On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of VYVANSE, the FDA determined that VYVANSE qualified as an NCE ... Shire: District Court Upholds FDAs Grant of 5-Year Exclusivity Wall Street Journal all 12 news articles » |
District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) MarketWatch (press release) On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of VYVANSE, the FDA determined that VYVANSE qualified as an NCE ... |